Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction.
|アブストラクト||We read with interest the pharmacovigilance study by Gupta and colleagues, who used the FDA Adverse Event Reporting System (FAERS) to explore the association between tumour necrosis factor (TNF) alpha inhibitors and suicidal behaviors (SB) in patients with hidradenitis suppurativa (HS).|
|ジャーナル名||Journal of the European Academy of Dermatology and Venereology : JEADV|
|投稿者||Raschi, Emanuel; Salvo, Francesco; La Placa, Michelangelo; Poluzzi, Elisabetta; De Ponti, Fabrizio|
|組織名||Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater;Studiorum, University of Bologna, Via Irnerio, 48, 40126, Bologna, Italy.;University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team;Pharmacoepidemiology, UMR 1219, F-33000, Bordeaux, France.;CHU de Bordeaux, Pole de sante Publique, Service de Pharmacologie medicale,;F-33000, Bordeaux, France.;Dermatology Division, Department of Experimental, Diagnostic and Specialty;Medicine, Policlinico S. Orsola-Malpighi, University of Bologna, Italy.|